あなたはまだ TradeKey.com のメンバーではないようです。 今すぐサインアップして、世界中で700万を超える輸入業者および輸出業者と接続します。 今すぐ加入、無料 |
BOOK A CALL
Book Call On Your Favorite Time
Code
🗘

By Signing Up. I agree to TradeKey.com Terms of Use, Privacy Policy, IPR and receive emails related to our services

Contact Us


Shanghai Yudiao Chemistry Technology Co., Ltd

Building A, NO.688,Qiushi Road,Jinshan District,Shanghai,shanghai,China China

無料会員
今すぐお問い合わせください
電話番号を表示
携帯電話番号を表示する
ホーム 会社 Shanghai Yudiao Chemistry Technology Co., Ltd 製品

製品: 15

raltegravir (free base) API
Raltegravir (free base) API

Raltegravir (MK-0518) is a potent inhibitor of human immunodeficiency virus (HIV) integrase and is clinically effective against viruses resistant to o

今すぐお問い合わせください
raltegravir k salt
Raltegravir k salt

871038-72-1, raltegravir, raltegravir K salt, N-(2-(4-(4-fluorobenzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1, 6-dihydropyrimidin-2-yl)propan-2-yl)-5-met

今すぐお問い合わせください
3-iodo-6-nitro-1-(tetrahydropyran-2-yl)-1H-indazole
3-iodo-6-nitro-1-(tetrahydropyran-2-yl)-1H-indazole

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.The drug

今すぐお問い合わせください
(E)-6-nitro-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
(E)-6-nitro-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.

今すぐお問い合わせください
(E)-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-amine
(E)-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-amine

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.The drug

今すぐお問い合わせください
(E)-6-iodo-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
(E)-6-iodo-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.The drug

今すぐお問い合わせください
(E)-N-methyl-2-(3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-ylthio)benzamide
(E)-N-methyl-2-(3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-ylthio)benzamide

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.The drug

今すぐお問い合わせください
2-mercapto-N-methylbenzamide
2-mercapto-N-methylbenzamide

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.

今すぐお問い合わせください
Axitinib API
Axitinib API

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.

今すぐお問い合わせください
masitinib API
Masitinib API

In vitro, masitinib had greater activity and selectivity against KIT than imatinib, inhibiting recombinant human wild-type KIT with an half inhibitory

今すぐお問い合わせください
1-Methyl-5-nitro-1H-benzimidazole-2-butanoic acid ethyl ester
1-Methyl-5-nitro-1H-benzimidazole-2-butanoic acid ethyl ester

Bendamustine was first synthesized in 1963 by Ozegowski and Krebs in East Germany (the former German Democratic Republic).

今すぐお問い合わせください
bendamustine HCl  API
Bendamustine HCl API

Bendamustine was first synthesized in 1963 by Ozegowski and Krebs in East Germany (the former German Democratic Republic).

今すぐお問い合わせください
(S)-tert-butyl 3-oxo-1-phenylpropylcarbamate
(S)-tert-butyl 3-oxo-1-phenylpropylcarbamate

A panel of four CCR5 monoclonal antibodies (mAbs) recognizing different epitopes on CCR5 was examined in CCR5-mediated cell-cell fusion assay

今すぐお問い合わせください
maraviroc API
Maraviroc API

A panel of four CCR5 monoclonal antibodies (mAbs) recognizing different epitopes on CCR5 was examined in CCR5-mediated cell-cell fusion assay

今すぐお問い合わせください
2-Amino-2-methylpropane nitrile
2-Amino-2-methylpropane nitrile

Raltegravir (MK-0518) is a potent inhibitor of human immunodeficiency virus (HIV) integrase and is clinically effective against viruses resistant to o

今すぐお問い合わせください

联系卖家

To:
Mr. James < Shanghai Yudiao Chemistry Technology Co., Ltd >
私は知りたい: